A review of records for two million patients in Canada, the UK, and USA, found that high potency statins are associated with an increased risk of acute kidney injury.
High potency statin treatment was defined as at least 10mg rosuvastatin, at least 20mg atorvastatin, or at least 40mg simvastatin; all other statin treatments were defined as having low potency.